Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Sweet’s syndrome in association with ipilimumab has been reported only briefly in the literature. However, neutrophilic infiltration has been seen in biopsies of patients with ipilimumab-associated enterocolitis.
Physicians should be aware of Sweet’s syndrome as a possible cutaneous side effect of ipilimumab therapy and be familiar with its management.
see also:
Adverse Events / Safety & Ipilimumab
…